インターベンショナルカーディオロジーデバイスの世界市場：洞察、競合情勢、市場予測：2030年

世界のインターベンショナルカーディオロジーデバイスの市場規模は、2023年に132億1,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に6.53％のCAGRで拡大し、2030年には193億1,000万米ドルに達すると予測されています。インターベンショナルカーディオロジーデバイスの需要は、主に、増加する高齢者人口における心血管疾患（CVD）の有病率の増加、製品開発における技術進歩、低侵襲手術の採用率の増加、予測期間中の心血管疾患に関する啓発プログラムの増加などによって後押しされています。

インターベンショナルカーディオロジーデバイス市場の成長に影響を与える主な要因の1つは、世界中で様々な心血管疾患の有病率が増加していることです。米国心臓協会（American Heart Association）2022年によると、2020年には全世界で約2億4,410万人が冠動脈（虚血）性心疾患を患っています。

高齢、肥満、喫煙など、何らかの形で心血管疾患の発症を引き起こす危険因子の増加が、インターベンショナルカーディオロジーデバイスの市場成長をさらに促進しています。例えば、WHOが提供したデータ（2023年）によると、2020年には世界中で約10億人が60歳以上でした。60歳以上の高齢者人口は2050年までに倍増し、約21億人に達すると予想されています。

このように、上記の疾患による有病率や死亡率の増加は、インターベンショナルカーディオロジーデバイスを用いた適切な治療によって管理または軽減することができるため、機器の需要増加につながります。したがって、前述の要因は、今後数年間、インターベンショナルカーディオロジーデバイス市場全体を押し上げることになります。

当レポートでは、世界のインターベンショナルカーディオロジーデバイス市場について調査し、市場の概要とともに、製品別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 インターベンショナルカーディオロジーデバイス市場レポートのイントロダクション

第2章 インターベンショナルカーディオロジーデバイス市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 インターベンショナルカーディオロジーデバイス市場の主な要因分析

• インターベンショナルカーディオロジーデバイス市場の促進要因
• インターベンショナルカーディオロジーデバイス市場の抑制要因と課題
• インターベンショナルカーディオロジーデバイス市場の機会

第5章 インターベンショナルカーディオロジーデバイス市場におけるポーターのファイブフォース分析

第6章 インターベンショナルカーディオロジーデバイス市場の概要

• 製品別
• 地域別

第7章 インターベンショナルカーディオロジーデバイスの企業と製品プロファイル

• Edwards Lifesciences Corporation
• Abbott Laboratories
• Boston Scientific Corporation
• ACIST Medical Systems
• F. Hoffmann-La Roche Ltd
• Siemens Healthcare GmbH
• Medtronic PLC.
• Teleflex Incorporated
• B Braun Melsungen AG
• MicroPort Scientific Corporation
• SIS MEDICAL AG
• Lepu Medical Technology Co. Ltd.
• Terumo Corporation
• Sahajanand Laser Technology Limited
• Biotronik SE & Co. KG

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Interventional Cardiology Devices Market in Global (2021-2030)
• Table 3: Interventional Cardiology Devices Market in Global by Product (2021-2030)
• Table 4: Interventional Cardiology Devices Market in Global by Geography (2021-2030)
• Table 5: Interventional Cardiology Devices Market in North America (2021-2030)
• Table 6: Interventional Cardiology Devices Market in the US (2021-2030)
• Table 7: Interventional Cardiology Devices Market in Canada (2021-2030)
• Table 8: Interventional Cardiology Devices Market in Mexico (2021-2030)
• Table 9: Interventional Cardiology Devices Market in Europe (2021-2030)
• Table 10: Interventional Cardiology Devices Market in France (2021-2030)
• Table 11: Interventional Cardiology Devices Market in Germany (2021-2030)
• Table 12: Interventional Cardiology Devices Market in the United Kingdom (2021-2030)
• Table 13: Interventional Cardiology Devices Market in Italy (2021-2030)
• Table 14: Interventional Cardiology Devices Market in Spain (2021-2030)
• Table 15: Interventional Cardiology Devices Market in Rest of Europe (2021-2030)
• Table 16: Interventional Cardiology Devices Market in Asia-Pacific (2021-2030)
• Table 17: Interventional Cardiology Devices Market in China (2021-2030)
• Table 18: Interventional Cardiology Devices Market in Japan (2021-2030)
• Table 19: Interventional Cardiology Devices Market in India (2021-2030)
• Table 20: Interventional Cardiology Devices Market in Australia (2021-2030)
• Table 21: Interventional Cardiology Devices Market in South Korea (2021-2030)
• Table 22: Interventional Cardiology Devices Market in Rest of Asia-Pacific (2021-2030)
• Table 23: Interventional Cardiology Devices Market in the Rest of the World (2021-2030)
• Table 24: Interventional Cardiology Devices Market in the Middle East (2021-2030)
• Table 25: Interventional Cardiology Devices Market in Africa (2021-2030)
• Table 26: Interventional Cardiology Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Interventional Cardiology Devices Market in Global (2021-2030)
• Figure 3: Interventional Cardiology Devices Market in Global by Product (2021-2030)
• Figure 4: Interventional Cardiology Devices Market in Global by Geography (2021-2030)
• Figure 5: Interventional Cardiology Devices Market in North America (2021-2030)
• Figure 6: Interventional Cardiology Devices Market in the US (2021-2030)
• Figure 7: Interventional Cardiology Devices Market in Canada (2021-2030)
• Figure 8: Interventional Cardiology Devices Market in Mexico (2021-2030)
• Figure 9: Interventional Cardiology Devices Market in Europe (2021-2030)
• Figure 10: Interventional Cardiology Devices Market in France (2021-2030)
• Figure 11: Interventional Cardiology Devices Market in Germany (2021-2030)
• Figure 12: Interventional Cardiology Devices Market in the United Kingdom (2021-2030)
• Figure 13: Interventional Cardiology Devices Market in Italy (2021-2030)
• Figure 14: Interventional Cardiology Devices Market in Spain (2021-2030)
• Figure 15: Interventional Cardiology Devices Market in the Rest of Europe (2021-2030)
• Figure 16: Interventional Cardiology Devices Market in Asia-Pacific (2021-2030)
• Figure 17: Interventional Cardiology Devices Market in China (2021-2030)
• Figure 18: Interventional Cardiology Devices Market in Japan (2021-2030)
• Figure 19: Interventional Cardiology Devices Market in India (2021-2030)
• Figure 20: Interventional Cardiology Devices Market in Australia (2021-2030)
• Figure 21: Interventional Cardiology Devices Market in South Korea (2021-2030)
• Figure 22: Interventional Cardiology Devices Market in the Rest of Asia-Pacific (2021-2030)
• Figure 23: Interventional Cardiology Devices Market in the Rest of the World (2021-2030)
• Figure 24: Interventional Cardiology Devices Market in the Middle East (2021-2030)
• Figure 25: Interventional Cardiology Devices Market in Africa (2021-2030)
• Figure 26: Interventional Cardiology Devices Market in South America (2021-2030)
• Figure 27: Market Drivers
• Figure 28: Market Barriers
• Figure 29: Market Opportunities
• Figure 30: PORTER's Five Force Analysis

Interventional Cardiology Devices Market By Product (Angioplasty Balloons [Drug-Eluting Balloons and Others], Angioplasty Stents [Drug-Eluting Stents, Bare-Metal Stents, and Bioabsorbable Stents], Structural Heart Devices [Aortic Valve Therapy Devices and Others], Catheters [Angiography Catheters, Guiding Catheters, and IVUS/OCT Catheters], Plaque Modification Devices [Atherectomy Devices and Thrombectomy Devices], Hemodynamic Flow Alteration Devices [Embolic Protection Devices and Chronic Total Occlusion Devices], and Others), and Geography, is expected to grow at a steady CAGR Forecast till 2030 owing to rising prevalence of cardiovascular diseases (CVDs) and surge in awareness programs regarding heart health

The global interventional cardiology devices market was valued at USD 13.21 billion in 2023, growing at a CAGR of 6.53% during the forecast period from 2024 to 2030, to reach USD 19.31 billion by 2030. The demand for interventional cardiology devices is primarily being boosted by the growing prevalence of cardiovascular diseases (CVDs) in the rising geriatric population, technological advancements in product development, the increasing adoption rates of minimally invasive surgeries, and increasing awareness programs regarding cardiovascular diseases among others during the forecast period.

Interventional Cardiology Devices Market Dynamics:

One of the key factors influencing the growth of the interventional cardiology devices market is the increasing prevalence of various cardiovascular diseases across the globe. According to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020.

As per the data provided by British Heart Foundation 2022, worldwide around 550 million were living with heart and circulatory diseases in 2019. The source further stated that coronary (ischemic) heart disease (200 million cases), peripheral arterial (vascular) disease (110 million cases), stroke (100 million cases), and atrial fibrillation (60 million cases) remained the most prevalent cardiovascular conditions worldwide in 2019.

According to Pan American Health Organization (PAHO) 2022, cardiovascular diseases cause more deaths yearly than any other disease. Heart disease and stroke-related fatalities account for more than three-quarters of all deaths in low- and middle-income nations, in 2021.

The increasing number of risk factors such as old age, obesity, smoking, and others causing the development of cardiovascular diseases in one or another way are further driving the market growth for interventional cardiology devices. For instance, according to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The elderly population aged 60 and above is expected to double in number representing about 2.1 billion people by 2050.

Thus, the increasing prevalence and mortality rate from the above-mentioned disorders can be either managed or reduced by providing proper treatment using interventional cardiology devices, thereby leading to an increased demand for the device. Therefore, the afore-said factor will propel the overall market of interventional cardiology devices in the upcoming years.

However, the availability of alternative treatments and product recalls may prove to be certain restraints to the interventional cardiology devices market growth.

Interventional Cardiology Devices Market Segment Analysis:

Interventional Cardiology Devices by Product (Angioplasty Balloons [Drug-Eluting Balloons and Others], Angioplasty Stents [Drug-Eluting Stents, Bare-Metal Stents, and Bioabsorbable Stents], Structural Heart Devices [Aortic Valve Therapy Devices and Others], Catheters [Angiography Catheters, Guiding Catheter, and IVUS/OCT Catheters], Plaque Modification Devices [Atherectomy Devices and Thrombectomy Devices], Hemodynamic Flow Alteration Devices [Embolic Protection Devices and Chronic Total Occlusion Devices], and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the interventional cardiology devices market, the drug-eluting balloons category under the angioplasty balloons segment will hold the majority of the global interventional cardiology devices market. This can be attributed to the advantages offered by drug-eluting balloons.

Drug-eluting balloons lead to an effective reduction in the narrowing of arteries, resulting in improved blood flow. It is considered one of the safest approaches with minimal procedural complications, and faster recovery periods. They offer immediate, homogenous, and sustained release of drug particles to the vessel wall. They can be used alone or in combination with a bare metal stent without many issues.

These balloons are devised in such a way that they hold the potential to inhibit cell division which in turn helps in limiting the amount of restenosis, or blockage re-growth after treatment.

In order to cure atherosclerosis, in-stent restenosis, and lower the risk of late thrombosis without implanting a permanent foreign object, drug-eluting balloons serve to restore luminal vascularity.

In comparison to drug-eluting stents, the drug-eluting balloons can release and spread the drug more equivalently to the endothelial lining.

With the growing demand for drug-eluting balloons, numerous new products are being developed, approved, and launched in the market. For example, in February 2020 SELUTION SLR drug-eluting balloon by MedAlliance was awarded CE Mark approval for the treatment of peripheral artery disease.

Therefore, the above-mentioned factors are predicted to contribute to the increasing demand for this product type, thereby driving the growth of the overall interventional cardiology devices market.

North America is expected to dominate the overall Interventional Cardiology Devices Market:

North America is expected to dominate the overall interventional cardiology devices market during the forecast period. This domination is due to the increasing prevalence of cardiovascular diseases, rising geriatric population base prone to CVDs, and increasing product launches and approvals, among others which will propel the market of interventional cardiology devices in the United States.

The Centers for Disease Control and Prevention (CDC) 2022, estimated that about 20.1 million adults aged 20 and older had Coronary artery disease (CAD) in the US, in 2020. Also, the same source stated that in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack. Out of these, 605,000 are a first heart attack, 200,000 happen to people who have already had a heart attack and about 1 in 5 heart attacks are silent-the damage is done, but the person is not aware of it.

The well-established healthcare infrastructure in the country with supportive reimbursement programs covering the costs for the implantable devices as well as the procedure further encourage people to opt for such devices.

In February 2023, Phenox, a Wallaby Medical company, received the US Food and Drug Administration (FDA) 510(k) clearance for its Preset thrombectomy device indicated for the treatment of acute ischaemic stroke.

Considering the presence of a large patient pool in the US coupled with new product launches, the market for interventional cardiology devices looks promising in the United States.

Interventional Cardiology Devices Market Key Players:

Some of the key market players operating in the interventional cardiology devices market include Edwards Lifesciences Corporation, Abbott Laboratories, Boston Scientific Corporation, ACIST Medical Systems, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Medtronic PLC., Teleflex Incorporated, B Braun Melsungen AG, MicroPort Scientific Corporation, SIS MEDICAL AG Lepu Medical Technology Co. Ltd., Terumo Corporation, Sahajanand Laser Technology Limited, Biotronik SE & Co. KG and others.

Recent Developmental Activities in the Interventional Cardiology Devices Market:

In July 2021, Medtronic PLC, the global leader in medical technology, announced the launch of the Prevail(TM) drug-coated balloon (DCB) Catheter in Europe following the CE (Conformite Europeene) mark. The newest coronary DCB on the market, the Prevail DCB is used during percutaneous coronary intervention (PCI) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD).

In June 2020, Edward Lifesciences Corporation (US) received Chinese regulatory approval for the SAPIEN 3 Transcatheter Heart Valve for the treatment of patients suffering from severe, symptomatic aortic stenosis (AS) who are unable to undergo open-heart surgery.

Key Takeaways from the Interventional Cardiology Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the interventional cardiology devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global interventional cardiology devices market.

Various opportunities are available for the other competitor in the interventional cardiology devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for interventional cardiology devices market growth in the coming future?

Target Audience who can be benefited from this Interventional Cardiology Devices Market Report Study

Interventional Cardiology Devices providers

Research organizations and consulting companies

Interventional Cardiology Devices related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in interventional cardiology devices

Various end-users want to know more about the interventional cardiology devices market and the latest technological developments in the interventional cardiology devices market.

Frequently Asked Questions for Interventional Cardiology Devices Market:

What are interventional cardiology devices?

Interventional cardiology devices are used in the diagnosis and treatment of patients suffering from cardiovascular diseases. Such procedures lead to fewer patient injuries and ensure a faster recovery and, therefore, shorter hospital time.

What is the market for global interventional cardiology devices?

The global interventional cardiology devices market was valued at USD 13.21 billion in 2023, growing at a CAGR of 6.53% during the forecast period from 2024 to 2030, to reach USD 19.31 billion by 2030.

What are the drivers for global interventional cardiology devices?

The major drivers driving the demand for interventional cardiology devices are the growing prevalence of cardiovascular diseases (CVDs) in the rising geriatric population, technological advancements in product development, the increasing adoption rates of minimally invasive surgeries, and increasing awareness programs regarding cardiovascular diseases.

What are the key players operating in global interventional cardiology devices?

Some of the key market players operating in the interventional cardiology devices market include Edwards Lifesciences Corporation, Abbott Laboratories, Boston Scientific Corporation, ACIST Medical Systems, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Medtronic PLC., Teleflex Incorporated, B Braun Melsungen AG, MicroPort Scientific Corporation, SIS MEDICAL AG Lepu Medical Technology Co. Ltd., Terumo Corporation, Sahajanand Laser Technology Limited, Biotronik SE & Co. KG and others.

What regions have the highest share in the interventional cardiology devices market?

North America is expected to dominate the overall interventional cardiology devices market during the forecast period, 2024 to 2030. This domination is due to the growing prevalence of cardiovascular diseases, access to better healthcare infrastructure coupled with the presence of major market players in the region.

Table of Contents

1. Interventional Cardiology Devices Market Report Introduction

2. Interventional Cardiology Devices Market Executive Summary

• 2.1 Scope of the Study
• 2.2 Market at Glance
• 2.3 Competitive Assessment

3. Regulatory Analysis

• 3.1 The United States
• 3.2 Europe
• 3.3 Japan
• 3.4 China

4. Interventional Cardiology Devices Market Key Factors Analysis

• 4.1. Interventional Cardiology Devices Market Drivers
  • 4.1.1. Growing prevalence of cardiovascular diseases (CVDs) and their risk factors
  • 4.1.2. Technological advancements in product development
  • 4.1.3. Increasing adoption rates of minimally invasive surgeries
  • 4.1.4. Increasing awareness programs regarding cardiovascular diseases
• 4.2. Interventional Cardiology Devices Market Restraints and Challenges
  • 4.2.1. Availability of alternative treatments
  • 4.2.2. Product recalls
• 4.3. Interventional Cardiology Devices Market Opportunities
  • 4.3.1. Increasing health awareness in emerging countries
  • 4.3.2. Use and availability of stents - which is bio-adaptive, smart, and anti-bacterial5. Interventional Cardiology Devices Porter's Five Forces Analysis
• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. Interventional Cardiology Devices Market Layout

• 6.1. By Product
  • 6.1.1. Angioplasty Balloons
    • 6.1.1.1. Drug-Eluting Balloons
    • 6.1.1.2. Others
  • 6.1.2. Angioplasty Stents
    • 6.1.2.1. Drug-Eluting Stents
    • 6.1.2.2. Bare-Metal Stents
    • 6.1.2.3. Bioabsorbable Stents
  • 6.1.3. Structural Heart Devices
    • 6.1.3.1. Aortic Valve Therapy Devices
    • 6.1.3.2. Others
  • 6.1.4. Catheters
    • 6.1.4.1. Angiography Catheters
    • 6.1.4.2. Guiding Catheters
    • 6.1.4.3. IVUS/OCT Catheters
  • 6.1.5. Plaque Modification Devices
    • 6.1.5.1. Atherectomy Devices
    • 6.1.5.2. Thrombectomy Devices
  • 6.1.6. Hemodynamic Flow Alteration Devices
    • 6.1.6.1. Embolic Protection Devices
    • 6.1.6.2. Chronic Total Occlusion Devices
  • 6.1.7. Others
• 6.2 By Geography
  • 6.2.1. North America Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.1.1. United States Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.1.2. Canada Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.1.3. Mexico Interventional Cardiology Devices Market in USD million (2021-2030)
  • 6.2.2. Europe Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.2.1. France Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.2.2. Germany Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.2.3. United Kingdom Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.2.4. Italy Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.2.5. Spain Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.2.6. Rest of Europe Interventional Cardiology Devices Market in USD million (2021-2030)
  • 6.2.3. Asia-Pacific Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.3.1. China Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.3.2. Japan Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.3.3. India Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.3.4. Australia Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.3.5. South Korea Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.3.6. Rest of Asia-Pacific Interventional Cardiology Devices Market in USD million (2021-2030)
  • 6.2.4. Rest of the World (RoW) Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.4.1. Middle East Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.4.2. Africa Interventional Cardiology Devices Market in USD million (2021-2030)
    • 6.2.4.3. South America Interventional Cardiology Devices Market in USD million (2021-2030)

7. Interventional Cardiology Devices Company and Product Profiles

• 7.1. Edwards Lifesciences Corporation
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Abbott Laboratories
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Boston Scientific Corporation
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. ACIST Medical Systems
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. F. Hoffmann-La Roche Ltd
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Siemens Healthcare GmbH
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Medtronic PLC.
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Teleflex Incorporated
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. B Braun Melsungen AG
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. MicroPort Scientific Corporation
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. SIS MEDICAL AG
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. Lepu Medical Technology Co. Ltd.
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Terumo Corporation
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. Sahajanand Laser Technology Limited
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Biotronik SE & Co. KG
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us